CXCL9 Antikörper (AA 23-125)

Produktnummer ABIN741930

Dieser Anti-CXCL9 Antikörper ist ein Kaninchen Polyklonal Antikörper zur Detektion von CXCL9 in WB, ELISA, IHC (p), IF (cc), IF (p) und IHC (fro). Geeignet für Human, Maus, Ratte und Schwein. Dieses Primary Antibody wurde in 8+ Publikationen zitiert.

Kurzübersicht für CXCL9 Antikörper (AA 23-125) (ABIN741930)

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Reaktivität: Human, Maus, Ratte, Schwein

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CXCL9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-CXCL9 Antikörper

Bindungsspezifität: AA 23-125

Kreuzreaktivität: Human, Maus, Schwein, Ratte

Homologie: Cow,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CXCL9

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Referenzen für anti-CXCL9 Antikörper (ABIN741930)

Lee, Cho, Cho, Bae, Kim, Park: "Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation." in: Laboratory animal research, Vol. 34, Issue 1, pp. 1-10, (2018) (PubMed).

Shimoura, Nagai, Fujiwara, Jimbo, Yoshimoto, Nishigori: "Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia." in: Archives of dermatological research, Vol. 309, Issue 4, pp. 315-321, (2017) (PubMed).

Yada, Iimuro, Uyama, Uda, Okada, Fujimoto: "Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages." in: Journal of hepatology, Vol. 63, Issue 4, pp. 905-16, (2016) (PubMed).

Sawano, Shimizu, Yamada, Nanashima, Miura, Morohashi, Kudo, Hui, Kijima, Hakamada, Tsuchida: "Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan." in: Oncology reports, Vol. 33, Issue 5, pp. 2151-60, (2015) (PubMed).

Zhang, Hu, Liu, Ye, Gui, Zhou, Qi, He, Wang, Wang: "CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment." in: Scientific reports, Vol. 5, pp. 15948, (2015) (PubMed).

Cai, Jiang, Pan, Chen, Zhang, Zhu, Cai, Ling, Chen, Xu, Chen: "Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol diet." in: BMC genomics, Vol. 16, pp. 59, (2015) (PubMed).

Clancy-Thompson, Perekslis, Croteau, Alexander, Chabanet, Turk, Huang, Mullins: "Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease." in: Cancer immunology research, Vol. 3, Issue 8, pp. 956-67, (2015) (PubMed).

Details zu CXCL9

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Andere Bezeichnung: CXCL9/MIG

Hintergrund:

Synonyms: CMK, MIG, Humig, SCYB9, crg-1, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Monokine induced by interferon-gamma, Small-inducible cytokine B9, CXCL9

Background: Cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. Chemotactic for activated T-cells. Binds to CXCR3.

Gen-ID: 4283

UniProt: Q07325